"The end of the beginning": molecular and cellular biology of gene therapy keystone. 14-20 January 1999.
Brenner
M K
MK
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
D000818:Animals; D017690:Cell Transplantation; D002986:Clinical Trials as Topic; D016228:Endothelial Growth Factors / Q000235:genetics; D005786:Gene Expression Regulation; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D008081:Liposomes; D008222:Lymphokines / Q000235:genetics; D015735:Mifepristone / Q000494:pharmacology; D010957:Plasmids / Q000235:genetics; D011956:Receptors, Cell Surface; D020123:Sirolimus / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D019076:Transgenes; D014589:Utah; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008081:Liposomes; D008222:Lymphokines; D011956:Receptors, Cell Surface; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; C052276:factor IX-IXa receptor; D015735:Mifepristone; D013752:Tetracycline; D020123:Sirolimus